Foothill Ventures
Venture Capital
Active
Los Altos, United States
88
8M
67
12.57
4
0.23
1
- Stages of investment
- Areas of investment
Summary
Tsingyuan Ventures appeared to be the VC, which was created in 2017. The main department of described VC is located in the Los Altos. The venture was found in North America in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Apps. Among the various public portfolio startups of the fund, we may underline Quantapore, Stimwave Technologies, eCreditpal The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The important activity for fund was in 2017. The fund is constantly included in 7-12 investment rounds annually. Comparing to the other companies, this Tsingyuan Ventures performs on 25 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 5 - 10 millions dollars. Considering the real fund results, this VC is 16 percentage points less often commits exit comparing to other organizations.
The overall number of key employees were 9.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Tsingyuan Ventures, startups are often financed by Grace Beauty Capital, TSVC, Startup Capital Ventures. The meaningful sponsors for the fund in investment in the same round are Baidu Ventures, ZMT Capital, Wisemont Capital. In the next rounds fund is usually obtained by ZMT Capital, TheVentureCity, Startup Capital Ventures.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 88
- Lead investments
- 4
- Exits
- 1
- Rounds per year
- 12.57
- Follow on index
- 0.23
- Investments by industry
- Software (22)
- Artificial Intelligence (18)
- Health Care (15)
- Biotechnology (12)
- Medical (12) Show 96 more
- Investments by region
-
- United States (79)
- China (6)
- Singapore (1)
- Canada (1)
- Peak activity year
- 2021
- Number of Unicorns
- 3
- Number of Decacorns
- 3
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 119M
- Group Appearance index
- 0.74
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
DeepHow | 27 Apr 2023 | Artificial Intelligence, Machine Learning, Manufacturing, Intelligent Systems, Service Industry | Early Stage Venture | 14M | United States, New York, New York |
UNIGRID | 13 Jun 2024 | Energy Storage, Sustainability, Battery | Early Stage Venture | 12M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.